COSM Cosmos Health Inc.

Nasdaq Wholesale-Drugs, Proprietaries & Druggists' Sundries NV CIK: 0001474167
AI RATING
STRONG_SELL
90% Confidence

Investment Thesis

Cosmos Health is operationally unprofitable with negative cash flow, burning through minimal cash reserves at an unsustainable rate. The company's critically weak 7.7% gross margin in the low-margin wholesale drug distribution business cannot support operating expenses, leaving only 5-6 months of cash runway before potential liquidity crisis.

Strengths

  • + Revenue growing 19.9% year-over-year demonstrates persistent market demand
  • + Reasonable debt/equity ratio of 0.17x avoids extreme leverage risk
  • + EPS improving 46.2% YoY from prior year loss indicates partial cost control progress

Risks

  • ! Catastrophic cash depletion: $514.7K cash against $1.1M quarterly operating cash burn provides critical liquidity crisis within months
  • ! Negative operating cash flow proves core business is value-destructive; company cannot self-fund operations
  • ! Gross margin of 7.7% structurally insufficient to cover operating expenses in a low-margin wholesale distribution business

Key Metrics to Watch

Financial Metrics

Revenue
17.9M
Net Income
-2.8M
EPS (Diluted)
$-0.06
Free Cash Flow
-1.1M
Total Assets
62.4M
Cash
514.7K

Profitability Ratios

Gross Margin 7.7%
Operating Margin -12.2%
Net Margin -15.6%
ROE -14.1%
ROA -4.5%
FCF Margin -6.0%

Balance Sheet & Liquidity

Current Ratio
1.08x
Quick Ratio
0.92x
Debt/Equity
0.17x
Debt/Assets
68.2%
Interest Coverage
-5.16x
Long-term Debt
3.5M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-23T08:06:35.263140 | Data as of: 2026-03-31 | Powered by Claude AI